SCHEMBL24143294

SCHEMBL24143294

CN(C)SNCCc1cn(Cc2cccc(F)c2)c2cc(-c3ccncc3)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 11/20 0.47
▸ CYP19A1 P11511 1/20 0.41
▸ KMT2A Q03164 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ NTSR1 P30989 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CDK9 P50750 2/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.38
▸ MKNK2 Q9HBH9 1/20 0.38
▸ ICMT O60725 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ CDC7 O00311 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24143919 0.90 NR1D1 (0.47) NR1D1LMNAMKNK1MKNK2HTR6
SCHEMBL24143305 0.90 NR1D1 (0.47) NR1D1CYP19A1POLBHTR6
SCHEMBL24144642 0.90 NR1D1 (0.49) NR1D1CYP19A1KMT2AKDM4ELMNA
SCHEMBL24143255 0.90 NR1D1 (0.47) NR1D1MKNK1MKNK2ICMTHTR6
SCHEMBL24143217 0.86 NR1D1 (0.46) NR1D1KMT2AMEN1LMNA
SCHEMBL24143945 0.86 NR1D1 (0.48) NR1D1GSK3B
SCHEMBL24144664 0.85 NR1D1 (0.49) NR1D1CYP19A1KMT2AKDM4EMEN1
SCHEMBL24143286 0.85 NR1D1 (0.68) NR1D1
SCHEMBL24144679 0.84 NR1D1 (0.49) NR1D1HTR6GSK3B
SCHEMBL24144502 0.83 CYP19A1 (0.47) NR1D1CYP19A1KMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021263278-A1 REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-12-30 — — WO disclosed
Send feedback